معرفی
Dr Verinder Singh Sidhu is a Clinical Lecturer at the Central Clinical School within the University of Sydney's Faculty of Medicine and Health. His research focuses on venous thromboembolism (VTE) prophylaxis strategies in orthopaedic surgery, particularly comparing aspirin and enoxaparin efficacy in hip/knee arthroplasty patients. He leads the CRISTAL trial, a landmark cluster-randomized study evaluating anticoagulant protocols. His work also explores surgical innovations like 3D-printed models for complex cases, such as diastrophic dysplasia management.
Key research interests include clinical trial methodology, postoperative complication prevention, and improving patient adherence to prophylactic regimens. His publications consistently address optimizing surgical outcomes through evidence-based practices.
- Notable contributions: CRISTAL trial (2019-2024), systematic reviews on anticoagulant efficacy
- Focus areas: VTE prevention, surgical outcomes research, healthcare quality improvement
Dr Sidhu's research bridges clinical practice and translational science, emphasizing patient-centered outcomes through rigorous trial designs and innovative surgical techniques.
